Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

October 2000

Beware What Your Lab Competitor is Doing!

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

TODAY I WOULD LIKE TO SPEAK SPECIFICALLY to hospital lab administrators and owners of independent commercial laboratories. I would like to offer some friendly counsel: it’s time to pay careful attention to the most successful of your laboratory competitors. Undeniable evidence is mounting that traditional clinical laboratory management methods are inferior to new models of […]

To access this post, you must purchase The Dark Report.

Beware What Your Lab Competitor is Doing! Read More »

AML & Dynacare Next To Try a Public Offering

Laboratory Management / Robert Michel

CEO SUMMARY: There will be plenty of competition for investors’ dollars this fall. American Medical Laboratories and Dynacare will join Specialty Laboratories in the effort to place an initial public offering (IPO). Three laboratory companies coming to market during the same period will certainly demonstrate whether professional investors truly believe that good times lie ahead

To access this post, you must purchase The Dark Report.

AML & Dynacare Next To Try a Public Offering Read More »

IPO Is Major Strategy For American Med Labs

Laboratory Management / Robert Michel

CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial public offering of common stock will need to compete with

To access this post, you must purchase The Dark Report.

IPO Is Major Strategy For American Med Labs Read More »

ISO 9000 Growing Across Lab Divisions of Quest Diagnostics

Lean Six Sigma / Robert Michel

CEO SUMMARY: Currently the American healthcare system is struggling to evolve away from its “cottage industry” roots and adopt modern corporate management methods. Within the clinical laboratory industry, Quest Diagnostics Incorporated has staked out the high ground. Its strategic objective is to infuse the entire laboratory company with knowledge of specific management methods commonly known

To access this post, you must purchase The Dark Report.

ISO 9000 Growing Across Lab Divisions of Quest Diagnostics Read More »

Intel & iMcKesson Fund Study Of Doctor-Patient Email System

Laboratory Information Systems / Robert Michel

IT’S CONSUMER DEMAND which motivated Intel Corporation and iMcKesson LLC to fund a study of how state-of-the-art email connectivity benefits physicians and their patients. The study, announced on October 11, will be conducted at the University of Michigan Health System (UMHS) in Ann Arbor Michigan. Led by two internists, Steven J. Katz, M.D., M.P.H. and

To access this post, you must purchase The Dark Report.

Intel & iMcKesson Fund Study Of Doctor-Patient Email System Read More »

Advanced Health Technologies, ProxyMed, WebMD, ePhysician, Data Critical Corp.

Laboratory Information Systems / Robert Michel

Editor’s Note: There is a major push by many well-funded companies to convert lab test ordering and results reporting onto Web-enabled systems. Here’s a sampling of what some companies are attempting to accomplish. AHT, MAKER OF DR.CHART, FILES BANKRUPTCY AND IS ACQUIRED BY BIOSHIELD FOLLOWING A SUMMER OF SQUABBLES with would-be acquirer Bioshield Technologies, AHT

To access this post, you must purchase The Dark Report.

Advanced Health Technologies, ProxyMed, WebMD, ePhysician, Data Critical Corp. Read More »

Dynacare Sets Sights On Raising $89 Million

Laboratory Management / Robert Michel

CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care contracts were common. Having survived in both countries, Dynacare now wants

To access this post, you must purchase The Dark Report.

Dynacare Sets Sights On Raising $89 Million Read More »

“October 23, 2000 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / Robert Michel

Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days ago. Lesser known is the fact that LabCorp executives Thomas McMahon and Brad Smith sold a total

To access this post, you must purchase The Dark Report.

“October 23, 2000 Intelligence: Late Breaking Lab News” Read More »

Management Execution Makes a Difference

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

THERE’S PLENTY OF HOOROAR AND EXCITEMENT about skyrocketing stock prices for several public lab and pathology companies in 2000! But this crusty old curmudgeon has been around the investment industry too long to accept Wall Street’s new-found enthusiasm for clinical laboratories as definitive proof of the lab industry’s financial turnaround. For example, it’s exciting to see

To access this post, you must purchase The Dark Report.

Management Execution Makes a Difference Read More »

Specialty Labs Prepares For Public Stock Offering

Laboratory Management / Robert Michel

CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock registration document with the SEC which provides new insights about the

To access this post, you must purchase The Dark Report.

Specialty Labs Prepares For Public Stock Offering Read More »

;